Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
<p><strong>Objectives</strong></p><p>Treat to target recommendations for PsA state that the target of treatment should be remission or, at the very least, low disease activity. Different clinical indexes have been proposed to define these disease states including the mi...
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Journal article |
| 出版事項: |
Oxford University Press
2018
|